Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Acacia Research | ACTG | Apr 24, 2024 | 4.98 | +0.20 |
Academy Sports and Outdoors | ASO | Apr 24, 2024 | 59.06 | -0.35 |
Acadia Healthcare | ACHC | Apr 24, 2024 | 71.19 | +0.64 |
Acadia Pharmaceuticals | ACAD | Apr 24, 2024 | 16.59 | -0.90 |
Acadia Realty Trust | AKR | Apr 24, 2024 | 17.46 | -1.13 |
Acasti Pharma A | ACST | Apr 24, 2024 | 2.90 | +0.69 |
Accel Entertainment | ACEL | Apr 24, 2024 | 11.50 | -1.54 |
Accelerate Diagnostics | AXDX | Apr 24, 2024 | 0.93 | -2.00 |
Accenture A | ACN | Apr 24, 2024 | 313.54 | -1.04 |
Acco Brands | ACCO | Apr 24, 2024 | 4.91 | -1.41 |
Accolade | ACCD | Apr 24, 2024 | 9.40 | +0.53 |
Accuray | ARAY | Apr 24, 2024 | 2.20 | -0.90 |
Ace Global Business Acquisition | ACBA | Apr 24, 2024 | 12.10 | 0.00 |
Ace Global Business Acquisition Unit | ACBAU | Apr 24, 2024 | 11.96 | 0.00 |
Acelyrin | SLRN | Apr 24, 2024 | 4.57 | -0.65 |
Achieve Life Sciences | ACHV | Apr 24, 2024 | 4.54 | +0.89 |
Achilles Therapeutics ADR | ACHL | Apr 24, 2024 | 0.78 | +0.35 |
ACI Worldwide | ACIW | Apr 24, 2024 | 33.33 | -0.39 |
Aclarion | ACON | Apr 24, 2024 | 0.29 | +2.20 |
Aclaris Therapeutics | ACRS | Apr 24, 2024 | 1.17 | -4.10 |
ACM Research A | ACMR | Apr 24, 2024 | 28.15 | +2.77 |
Acme United | ACU | Apr 24, 2024 | 41.21 | +1.85 |
ACNB | ACNB | Apr 24, 2024 | 33.98 | -0.79 |
Acorda Therapeutics | ACOR | Apr 24, 2024 | 0.88 | 0.00 |
ACRES Commercial Realty | ACR | Apr 24, 2024 | 13.59 | -2.72 |
ACRES Commercial Realty C Pref | ACR-C | Apr 24, 2024 | 24.20 | +1.30 |
ACRES Commercial Realty D Pref | ACR-D | Apr 24, 2024 | 20.54 | -1.25 |
Acrivon Therapeutics | ACRV | Apr 24, 2024 | 9.50 | -3.26 |
Actelis Networks | ASNS | Apr 24, 2024 | 0.80 | +2.66 |
Actinium Pharmaceuticals | ATNM | Apr 24, 2024 | 7.06 | +1.44 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.